PALLIATIVE PANCREATODUODENAL RESECTION IN PANCREATIC HEAD CANCER
https://doi.org/10.17709/2409-2231-2018-5-1-6
Abstract
Purpose. Evaluation of the effectiveness of the method of palliative pancreatoduodenal resection for complications of advanced pancreatic head cancer.
Patients and methods. The article analyzes the results of treatment of 32 patients with advanced pancreatic head cancer in the Department of Radiosurgery of the FSBO «N. Blokhin National Medical Research Center of Oncology” of Ministry of Health of Russia. All patients underwent palliative pancreatoduodenal resection. In terms of the prevalence of the process, the patients were distributed as follows: 17 (53.1%) patients with the locally advanced process and 15 (46.9%) patients with distant metastases.
Results. The average time of the operative intervention was 5.2 ± 0.3 hours, the average blood loss was 543.1 ± 1.3 ml, the average bed-day was 22.1 ± 0.6 days. In total, in the shortest postoperative period, complications were noted in 5 patients (15.6%). The total postoperative lethality after the PDR was 6.3%. In general, the results were divided into 4 groups: good results were recognized in 16.7% of cases, satisfactory enough — in 26.7%, less satisfactory, but a positive effect — in 50%, non-satisfactory results of treatment were found in 6.6% cases. Quality of life using the MOS-SF-36 questionnaire — if the average indicator on the scale of physical health was 41.2 ± 0.5 before the operation, then after a month of surgery it was significantly higher — 68.1 ± 0.9, according to the scale the average figure increased from 30.6 ± 0.9 to 71.5 ± 0.7. However, the differences between the values before and after surgery are statistically significant (p<0.01). The long-term survival rate for 1 year after the operation was 39.2%, 2 years after the surgery, 7.1%.
Conclusions. Palliative pancreatoduodenal resection with a common pancreatic cancer in some cases can be an operation of choice that effectively eliminates the underlying pathological process and its complications in the form of mechanical jaundice, duodenal obstruction and pain syndrome and significantly improve the quality of life of patients.
About the Authors
T. G. Gevorkyan
M.Vladimirskiy Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
Tigran G. Gevorkyan - Deputy Director for Organization of Cancer Care.
61/2, build. 1 Shchepkina str., Moscow 129110
I. A. Faynshteyn
Blokhin National Medical Research Center of Oncology of Ministry of Health of Russia
Russian Federation
Russian Federation
Igor А. Faynshteyn - MD, PhD, DSc, leading reseaecher of the Department of Radiosurgery.
24, Kashirskoe shosse, Moscow 115478
References
1. Wagner M, Zgraggen K, Vagianos C, Redaelli CA, Holzinger F, Sadowski C, et al. Pylorus-preserving total pancreatectomy. Dig Surg. 2001;18 (3):188–95. DOI: 10.1159/000050128
2. Walter J, Nier A, Rose T, Egberts JH, Schafmayer C, Kuechler T, et al. Palliativepartial pancreaticoduodenectomy impairs quality of life compared to bypass surgery in patients with advanced adenocarcinoma of thepancreatichead. Eur J Surg Oncol. 2011 Sep;37 (9):798–804. DOI: 10.1016/j.ejso.2011.06.017
3. Nieveen van Dijkum EJ1, Kuhlmann KF, Terwee CB, Obertop H, de Haes JC, Gouma DJ. Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg. 2005 Apr;92 (4):471–7. DOI: 10.1002/bjs.4887
4. Kasum’yan SA, Alibegov RA, Bel’kov AV, et al. Blizhaishie rezul’taty khirurgicheskogo lecheniya raka golovki podzheludochnoi zhelezy. Annaly Khirurgicheskoy Gepatologii (Annals Of Surgical Hepatology). 1998;3 (2):65–70. (In Russian).
5. Kubyshkin VA, Vishnevskii VA. Rak podzheludochnoi zhelezy [Pancreas cancer]. Мoscow: “Med-praktika” Publ., 2003, 386 p. (In Russian).
6. Allema JH, Reinders ME, van Gulik TM, Koelemay MJ, Van Leeuwen DJ, de Wit LT, et al. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer. 1995 Apr 15;75 (8):2069–76.
7. Johnstone PA, Sindelar WF. Radical reoperation for advanced pancreatic carcinoma. J Surg Oncol. 1996 Jan;61 (1):7–11; discussion 11–3. DOI: 10.1002/(SICI)1096–9098 (199601)61:1<7:: AID-JSO2>3.0.CO;2-H
8. Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeeb A, Sauter PK, et al. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg. 1996 Jun;223 (6):718–25; discussion 725–8.
9. Shrikhande SV, Kleeff J, Reiser C, Weitz J, Hinz U, Esposito I, et al. Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2007 Jan;14 (1):118–27. DOI: 10.1245/s10434–006–9131–8
10. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004 May;91 (5):586–94. DOI: 10.1002/bjs.4484
Review
For citations:
Gevorkyan T.G., Faynshteyn I.A. PALLIATIVE PANCREATODUODENAL RESECTION IN PANCREATIC HEAD CANCER. Research and Practical Medicine Journal. 2018;5(1):52-59. (In Russ.) https://doi.org/10.17709/2409-2231-2018-5-1-6
Views:
4349
Email this article 